CO5170469A1 - Un proceso para la sintesis de suspenciones antiperspirantes finamente divididas - Google Patents

Un proceso para la sintesis de suspenciones antiperspirantes finamente divididas

Info

Publication number
CO5170469A1
CO5170469A1 CO00039650A CO00039650A CO5170469A1 CO 5170469 A1 CO5170469 A1 CO 5170469A1 CO 00039650 A CO00039650 A CO 00039650A CO 00039650 A CO00039650 A CO 00039650A CO 5170469 A1 CO5170469 A1 CO 5170469A1
Authority
CO
Colombia
Prior art keywords
zirconium
suspentions
synthesis
aluminum
content
Prior art date
Application number
CO00039650A
Other languages
English (en)
Inventor
Johannes Breker
Klaus Schanz
Bruno Kauhmann
Wolfgang Reibel
Original Assignee
Bk Giulini Cheme Gmbh And Co O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bk Giulini Cheme Gmbh And Co O filed Critical Bk Giulini Cheme Gmbh And Co O
Publication of CO5170469A1 publication Critical patent/CO5170469A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/28Zirconium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58Metal complex; Coordination compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Colloid Chemistry (AREA)

Abstract

Suspensión antiperspirante de partícula finas en fase no acuosa, de efectividad mejorada, que contiene como ingrediente activo un complejo de aluminio-zirconio-halógeno hidrato que puede contener aminoácido, en donde el contenido de complejo de aluminio - zirconio - halógeno hidrato en la suspensión es de 0,1% a 70% en peso y el contenido de aminoácido en el complejo de aluminio - zirconio - halógeno hidrato es de 0 a 15% en peso y todos los componentes de la suspención forman el 100%, caracterizada porque mínimo 60% del contenido de zirconio se puede titular directamente después de disolverlo en 0,1 n HCI con EDTA a pH 0,8.
CO00039650A 1999-05-29 2000-05-29 Un proceso para la sintesis de suspenciones antiperspirantes finamente divididas CO5170469A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99110455A EP1057473B1 (de) 1999-05-29 1999-05-29 Feinteilige Aluminium und Zirkonium enthaltende Antiperspirant Suspensionen mit verbesserter Wirksamkeit und ein Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
CO5170469A1 true CO5170469A1 (es) 2002-06-27

Family

ID=8238263

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00039650A CO5170469A1 (es) 1999-05-29 2000-05-29 Un proceso para la sintesis de suspenciones antiperspirantes finamente divididas

Country Status (18)

Country Link
US (1) US6517819B1 (es)
EP (1) EP1057473B1 (es)
JP (1) JP2001031547A (es)
CN (1) CN1201722C (es)
AR (1) AR024149A1 (es)
AT (1) ATE230972T1 (es)
AU (1) AU779274B2 (es)
BR (1) BR0002517A (es)
CA (1) CA2309573C (es)
CO (1) CO5170469A1 (es)
DE (1) DE59904040D1 (es)
DK (1) DK1057473T3 (es)
ES (1) ES2191383T3 (es)
HK (1) HK1033266A1 (es)
MX (1) MXPA00005195A (es)
PT (1) PT1057473E (es)
TW (1) TWI225409B (es)
ZA (1) ZA200002673B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR031108A1 (es) * 2000-06-19 2003-09-10 Colgate Palmolive Co Un metodo para mejorar la actividad de una sal de aluminio o de aluminio/circonio que contiene especies de aluminio pequenas y grandes, las sales asi obtenidas y los productos antitranspirantes y/o desodorantes preparados con dichas sales mejoradas
US6726901B2 (en) * 2002-05-09 2004-04-27 The Gillette Company Stabilized antiperspirant compositions containing aluminum-zirconium salts with low M:Cl ratio
US7074394B2 (en) * 2003-07-22 2006-07-11 Reheis, Inc. Stable aluminum/zirconium antiperspirant solution free of amino acid and polyhydric alcohol
TWI388876B (zh) 2003-12-26 2013-03-11 Fujifilm Corp 抗反射膜、偏光板,其製造方法,液晶顯示元件,液晶顯示裝置,及影像顯示裝置
US7731943B2 (en) * 2004-07-07 2010-06-08 Summit Research Labs, Inc. Stabilized aqueous aluminum zirconium solutions
DE102008064198A1 (de) * 2008-12-22 2010-07-01 Henkel Ag & Co. Kgaa Transparente schweißhemmende Gele
CN104902869A (zh) 2012-12-14 2015-09-09 宝洁公司 个人护理组合物
CA3083225A1 (en) * 2017-12-14 2019-06-20 Colgate-Palmolive Company Zirconium-based cluster as an antiperspirant and deodorant active

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH18181A (en) * 1981-03-09 1985-04-12 Colgate Palmolive Co Anhydrous antiperspirant composition
GB2144992A (en) * 1983-08-16 1985-03-20 Gillette Co Antiperspirants
US5444096A (en) * 1989-06-02 1995-08-22 Helene Curtis, Inc. Stable anhydrous topically-active composition and suspending agent therefor
WO1991004009A1 (en) * 1989-09-15 1991-04-04 The Gillette Company Antiperspirant
EP0485012B1 (en) * 1990-11-08 1996-02-07 The Procter & Gamble Company Liquid antiperspirant composition
US5723135A (en) * 1996-02-06 1998-03-03 The Gillette Company One-phase process for making a clear antiperspirant stick containing dibenzylidene alditol
US6231259B1 (en) * 1996-07-26 2001-05-15 The Gillette Company Viscous product dispenser with porous dome
US5969172C1 (en) * 1998-06-12 2002-06-18 Gen Electric Silicone solvents for antiperspirant salts
US5955065A (en) * 1998-08-19 1999-09-21 The Gillette Company Antiperspirant compositions containing calcium salts
US6136302A (en) * 1999-02-18 2000-10-24 The Procter & Gamble Company Process of making zirconium-aluminum antiperspirant active

Also Published As

Publication number Publication date
TWI225409B (en) 2004-12-21
AR024149A1 (es) 2002-09-04
DK1057473T3 (da) 2003-05-05
AU779274B2 (en) 2005-01-13
EP1057473B1 (de) 2003-01-15
AU3780500A (en) 2000-11-30
CA2309573C (en) 2003-09-16
MXPA00005195A (es) 2002-03-08
CN1201722C (zh) 2005-05-18
DE59904040D1 (de) 2003-02-20
EP1057473A1 (de) 2000-12-06
CN1279060A (zh) 2001-01-10
CA2309573A1 (en) 2000-11-29
JP2001031547A (ja) 2001-02-06
BR0002517A (pt) 2001-11-13
ES2191383T3 (es) 2003-09-01
ZA200002673B (en) 2001-05-10
PT1057473E (pt) 2003-06-30
HK1033266A1 (en) 2001-08-24
US6517819B1 (en) 2003-02-11
ATE230972T1 (de) 2003-02-15

Similar Documents

Publication Publication Date Title
BR112012015725A2 (pt) composição antitranspirante/desodorante aquosa
UY29963A1 (es) Compuestos terapéuticos: piridinas y pirazinas como andamios
CY1109568T1 (el) Ενωσεις βενζο(d)ισοξαζολ-3-υλαμινης και η χρησιμοποιηση τους σαν προσδεματα υποδοχεα βανιλλοειδων
BR0111377A (pt) Derivados de tiofeno úteis como agentes anticancerìgenos
BRPI0708038B8 (pt) derivado de cumarina, composição farmacêutica e agente terapêutico para um distúrbio proliferativo celular
BR0309528A (pt) Comprimido com alta carga de droga
MXPA03007249A (es) Compuestos triazolo como inhibidores de mmp.
PE20090840A1 (es) Moleculas pequenas que contienen boro
DK0850221T3 (da) Meta-guanidin-, urinstof-, thiourinstof- eller azacykliske aminobenzoesyrederivater som intergrinantagonister
AR034132A1 (es) Analogos de somatostatina, un proceso para su produccion y composicion farmaceutica
AR082825A2 (es) Inhibidores heterociclicos nitrogenados de mek, composiciones farmaceuticas que los contienen, metodos para prepararlos y uso de los mismos para el tratamiento de trastornos hiperproliferativos o inflamatorios
ECSP056016A (es) Nuevos derivados de 2-piridinacarboxamida
MY138941A (en) Aryl-pyridine derivatives
BR0315815A (pt) Agentes para prevenir ou tratar neuropatia, para promover a produção ou a secreção de um fator neurotrópico, para melhorar a dor, neuroprotetor e farmacêutico, composto, métodos para prevenir ou tratar neuropatia e para promover a produção ou a secreção de um fator neurotrópico, para melhorar a dor para proteger um nervo em um mamìfero e para produzir um composto e uso de um composto
TW200603790A (en) Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis
TR200201874T2 (tr) Proteaz inhibitörleri olarak yeni bileşikler ve bileşimler.
CO5170469A1 (es) Un proceso para la sintesis de suspenciones antiperspirantes finamente divididas
BRPI0508768A (pt) derivado de benzopirano da fórmula (i) ou (ii), ou sal farmaceuticamente aceitável do mesmo, medicamento e medicamento para o tratamento de arritmia
RS20060190A (en) Bicyclic /3.1.0/ derivatives as glycine transporter inhibitors
DOP2001000288A (es) Formas de sal de amida de acido3-(4-bromo-2,6-difluoro-benciloxi)-5-(3-(4-pirrolidin - 1 - ilbutil) ureidoisitiazol - 4 - carboxilico y método de producción
BRPI0408353A (pt) composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto
EA201592237A1 (ru) Способ получения состава, содержащего аморфный гидрат окиси железа
EA201291327A1 (ru) Замещенные 6-метилникотинамиды как позитивные аллостерические модуляторы mglur5
EA201170546A1 (ru) Новые гетероциклические азотсодержащие соединения, их получение и их применение в качестве антибактериальных лекарственных средств
WO2004094369A3 (en) Stabilized derivatives of ascorbic acid

Legal Events

Date Code Title Description
FD Application lapsed